Logo

American Heart Association

  19
  0


Final ID:

Association Between the Resuscitation Quality Improvement Program for CPR Training and Cardiac Arrest Survival in Hospitals

Abstract Body: This is a Promissory Abstract, and we will divulge actual results at ReSS

Importance: Since 2018, the Resuscitation Quality Improvement® (RQI) program to enhance cardiopulmonary resuscitation (CPR) skill retention through low-dose, high-frequency training has expanded to many U.S. hospitals.
Objective: Evaluate whether implementation of the RQI Provider program is associated with higher in-hospital cardiac arrest (IHCA) survival, compared with control (non-RQI) hospitals.
Design: Cohort study of 237 U.S. hospitals participating in Get With The Guidelines-Resuscitation during 2017-2023. Control hospitals were uniquely matched to a RQI hospital if they had a 2-year risk-standardized survival rate (RSSR) to discharge that was within 1% of the RQI hospital’s RSSR during the 2-year preintervention period before RQI adoption, and both had annual IHCA case volume that was within 50 cases of each other. Hierarchical models were used to conduct a difference-in-difference analysis to compare the 2-year postintervention vs. 2-year preintervention IHCA survival rates at RQI vs. control hospitals.
Exposure: Implementation of the RQI Provider program.
Main Outcomes: RSSR to hospital discharge (primary outcome) and return of spontaneous circulation (secondary outcome).
Results: Of 237 hospitals, 107 control hospitals were matched to 18 RQI hospitals (5 in 2019, 8 in 2020, and 5 in 2021), comprising a total of 49,870 IHCAs. Mean RSSR to hospital discharge at RQI hospitals was X% + X% in the preintervention period and X% + X% in the postintervention period, whereas mean RSSR at control hospitals was X% + X% and X% + X%. When postintervention vs. preintervention survival rates were compared between the groups, RQI adoption was (or was not) associated with improvements in survival to discharge (difference-in-difference adjusted OR: X.XX [95% CI: X.XX, X.XX]; P=0.XX). For ROSC, mean RSSR at RQI hospitals was X% + X% and X% + X% in the preintervention and postintervention periods whereas it was X% + X% and X% + X% at control hospitals. When postintervention vs. preintervention ROSC rates were compared, RQI adoption was (or was not) associated with higher rates of ROSC (difference-in-difference adjusted OR: X.XX [95% CI: X.XX, X.XX]; P=0.XX).
Conclusions: In a national registry of IHCA, compared to control hospitals, hospital adoption of the RQI Provider program was (or was not) associated with improved rates of survival to discharge and ROSC in the two years after implementation.
  • Chan, Paul  ( MID AMERICA HEART INSTITUTE , Kansas City , Missouri , United States )
  • Bradley, Steven  ( MINNEAPOLIS HEART INSTITUTE , Minneapolis , Minnesota , United States )
  • Spertus, John  ( Saint Lukes Mid America Heart Inst , Kansas City , Missouri , United States )
  • Fu, Zhuxuan  ( SAINT LUKES MID AMERICA HEART INST , Kansas City , Missouri , United States )
  • Jones, Philip  ( SAINT LUKES MID AMERICA HEART INST , Kansas City , Missouri , United States )
  • Rolston, Daniel  ( Northwell Health , Long Island City , New York , United States )
  • Girotra, Saket  ( University of Texas Southwestern , Dallas , Texas , United States )
  • Author Disclosures:
    Paul Chan: DO have relevant financial relationships ; Research Funding (PI or named investigator):American Heart Association:Active (exists now) ; Researcher:NHLBI:Active (exists now) | Steven Bradley: DO NOT have relevant financial relationships | John Spertus: DO have relevant financial relationships ; Independent Contractor:BioHaven, Janssen, Bristol Meyers Squibb, Terumo, Cytokinetics, BridgeBio, VentricHealth, and Imbria:Active (exists now) ; Other (please indicate in the box next to the company name):Blue Cross Blue Shield of Kansas City:Active (exists now) ; Ownership Interest:Outcomes Instruments:Active (exists now) ; Research Funding (PI or named investigator):National Institutes of Health, the Patient-Centered Outcomes Research Institute, the American College of Cardiology Foundation, Lexicon, Imbria, and Janssen:Active (exists now) | Zhuxuan Fu: No Answer | Philip Jones: No Answer | Daniel Rolston: DO have relevant financial relationships ; Research Funding (PI or named investigator):Flosonics:Active (exists now) ; Research Funding (PI or named investigator):Philips:Expected (by end of conference) | Saket Girotra: DO NOT have relevant financial relationships
Meeting Info:

Resuscitation Science Symposium 2025

2025

New Orleans, Louisiana

Session Info:

Late-Breaking Resuscitation Science Abstracts

Saturday, 11/08/2025 , 10:00AM - 11:00AM

ReSS25 Plenary Session

More abstracts on this topic:
Abdominal Aortic Compression with Ultrasound is Safe and Demonstrates Effect on Cardiac Output in Healthy Volunteers on Non-Invasive Hemodynamic Monitoring

Jafry Zan, Truong Natalie, Dinh Vi, Joe Yuna

30-day and one-year outcomes of patients with severe aortic stenosis after TAVI using Myval : A Meta-analysis

Hasabo Elfatih A., Sultan Sherif, Soliman Osama, A. Aboali Amira, Hemmeda Lina, Salah Alaa, Alrawa Salma S., Elgadi Ammar, Abdalmotalib Malaz, Yasir H Eissa Abdullatif, Mahmmoud Fadelallah Eljack Mohammed

More abstracts from these authors:
Body Mass Index and Outcomes of In-Hospital Cardiac Arrest

Ikemura Nobuhiro, Abdel Jawad Mohammad, Cho Yoon, Jones Philip, Spertus John, Chan Paul

Residual Angina Following Anatomic Complete Revascularization for Chronic Coronary Disease in the ISCHEMIA Trial: Frequency, Characteristics, and Outcomes

Singh Ayesha, Stone Gregg, Bangalore Sripal, Spertus John, Maron David, Hochman Judith, Brown David, Jones Philip, Fu Zhuxuan, Reynolds Harmony, Boden William, Obrien Sean, Mavromatis Kreton, Ali Ziad

You have to be authorized to contact abstract author. Please, Login
Not Available